Signature Financial Management’s Biogen BIIB Stock Holding History

Signature Financial Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-767	Closed	-$202K	–	120
2017 Q3	$202K	Buy	+767	New	+$227K	0.06%	156
2015 Q3	–	Sell	-668	Closed	-$270K	–	100
2015 Q2	$270K	Hold	668	–	–	0.17%	72
2015 Q1	$282K	Sell	668 -220	-25%	-$86.7K	0.18%	65
2014 Q4	$301K	Hold	888	–	–	0.21%	61
2014 Q3	$294K	Sell	888 -225	-20%	-$74.2K	0.21%	67
2014 Q2	$351K	Buy	1,113 +33	+3%	+$9.93K	0.27%	50
2014 Q1	$330K	Hold	1,080	–	–	0.28%	53
2013 Q4	$302K	Hold	1,080	–	–	0.24%	59
2013 Q3	$260K	Hold	1,080	–	–	0.23%	58
2013 Q2	$233K	Buy	+1,080	New	+$231K	0.16%	62

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Signature Financial Management's BIIB Position: Q4 2017 in Review

Signature Financial Management sold out of Biogen (BIIB) in Q4 2017, closing a stake of 767 shares — an estimated $202K sold.

Signature Financial Management first reported a position in BIIB in Q2 2013 and held it in 10 quarters. The position peaked at $351K in Q2 2014. 1,123 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

Signature Financial Management reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
Signature Financial Management sold 767 Biogen shares in Q4 2017, an estimated $202K.
Signature Financial Management first reported a position in Biogen in Q2 2013 and held it in 10 quarters.
Signature Financial Management's Biogen position peaked at $351K in Q2 2014.
1,123 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Signature Financial Management's 13F filing for Q4 2017, filed 9 Feb 2018.